Company profile

Haisco Pharmaceutical Group

Diversified pharma

002653 · SZSE · China

Public Market Listing

002653SZSE

SZSE primary exchange listing

Live quotes, historical charts, and market capitalization for Haisco Pharmaceutical Group are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(9 total)
9Total Assets
0Approved
4Phase 3 / Filed
5Phase 1–2 / Early
8Diseases
Quick filter:
Showing 9 of 9 assets
Target & Modality
Anrikefon (HSK21542)
Phase 3
Kappa-opioid receptor (agonist, peripherally restricted)Small molecule
Chronic Kidney Disease
Crisugabalin
Phase 3
α2δ-1 subunit of voltage-gated calcium channelsSmall molecule
Diabetic Peripheral Neuropathic Pain
HSK39004
Phase 3
Phosphodiesterase 3 and Phosphodiesterase 4 (PDE3/PDE4)Small molecule
Chronic Obstructive Pulmonary Disease
HSK7653
Phase 3
GLP-1 receptorPeptide
Type 2 Diabetes
HSK44459
Phase 2
PDE4BSmall molecule
Atopic DermatitisPsoriasis
HSK47388
Phase 2
IL-17 · TNF-alphaSmall molecule
Inflammatory Bowel DiseasePsoriasis
Ulcerative Colitis
HSK40118
Phase 1
EGFRSmall molecule
Non-Small Cell Lung Cancer
HSK41959
Phase 1
MAT2ASmall molecule
Non-Small Cell Lung Cancer
Cofrogliptin
Preclinical
DPP-4Small molecule
Type 2 Diabetes

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.